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Temporal retinal transcriptome 
and systems biology analysis 
identifies key pathways and hub 
genes in Staphylococcus aureus 
endophthalmitis
Deepa Rajamani4,*, Pawan Kumar Singh1,2,*, Bruce G. Rottmann2, Natasha Singh4, 
Manoj K. Bhasin4,5 & Ashok Kumar1,2,3
Bacterial endophthalmitis remains a devastating inflammatory condition associated with permanent 
vision loss. Hence, assessing the host response in this disease may provide new targets for intervention. 
Using a mouse model of Staphylococcus aureus (SA) endophthalmitis and performing retinal 
transcriptome analysis, we discovered progressive changes in the expression of 1,234 genes. Gene 
ontology (GO) and pathway analyses revealed the major pathways impacted in endophthalmitis 
includes: metabolism, inflammatory/immune, antimicrobial, cell trafficking, and lipid biosynthesis. 
Among the immune/inflammation pathways, JAK/Stat and IL-17A signaling were the most significantly 
affected. Interactive network-based analyses identified 13 focus hub genes (IL-6, IL-1β, CXCL2, STAT3, 
NUPR1, Jun, CSF1, CYR61, CEBPB, IGF-1, EGFR1, SPP1, and TGM2) within these important pathways. 
The expression of hub genes confirmed by qRT-PCR, ELISA (IL-6, IL-1β, and CXCL2), and Western blot 
or immunostaining (CEBP, STAT3, NUPR1, and IGF1) showed strong correlation with transcriptome 
data. Since TLR2 plays an important role in SA endophthalmitis, counter regulation analysis of TLR2 
ligand pretreated retina or the use of retinas from TLR2 knockout mice showed the down-regulation 
of inflammatory regulatory genes. Collectively, our study provides, for the first time, a comprehensive 
analysis of the transcriptomic response and identifies key pathways regulating retinal innate responses 
in staphylococcal endophthalmitis.
Despite several advances in ocular surgeries, including sutureless and minimally invasive procedures, infectious 
endophthalmitis remains one of the most concerning postsurgical complications due to its ability to cause blind-
ness1–3. The incidence of endophthalmitis varies with the surgical procedure performed, but it is most likely 
to develop following cataract surgery/intraocular lens implantation, with the incidence ranging from 0.07% to 
0.4%4,5. This reported incidence represents a significant public health problem, as > 3.4 million cataract surgeries 
are performed in the United States annually, and over 19.5 million performed worldwide6,7. Moreover, the inci-
dence of endophthalmitis is expected to grow in the near future due to the increased use of multiple intravitreal 
injections (IVTs) for the treatment of age-related macular degeneration (AMD) and diabetic retinopathy (DR)8,9.
The visual outcome following endophthalmitis largely depends upon the virulence potential of the infect-
ing pathogen and the dynamic interplay between the host and the pathogen10,11. For example, eye infected with 
Staphylococcus epidermidis exhibit mild acute inflammatory response and the infection is resolved quickly, with 
restoration of visual acuity close to normal12–14. In contrast, inoculation of the eye with the other Gram-positive 
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bacteria, such as Bacillus cereus15–18 and S. aureus3,19–23, results in severe intraocular inflammation, retina tissue 
damage, and loss of vision within 24 to 96 h post-infection, respectively. However, regardless of the nature of the 
pathogens, the common host response to an infection, including endophthalmitis, is the generation of inflamma-
tory responses. In the past decade, extensive studies from our laboratory and others have provided a considerable 
wealth of information on how innate responses are initiated in the retina during endophthalmitis.
One of the cardinal steps in initiating an innate immune response is pathogen recognition by specific receptors 
present on innate immune cells24. The best characterized class of receptors which the host employs are called the 
Toll-like receptors (TLRs)25, whose discovery has opened up a wide range of therapeutic opportunities for various 
infectious and inflammatory diseases26. Consequently, the role of TLRs has also been well-established in ocular 
infections27, including bacterial endophthalmitis19,20,28–31. We previously reported that TLR2 plays an important 
role in innate immune responses in SA endophthalmitis2,19,31–33. Moreover, we showed that TLR2-activation prior 
to SA infection attenuated the development of endophthalmitis in a mouse model20. Furthermore, TLR2 ligand 
Pam3Cys (Pam3) pretreatment was found to reduce the inflammatory response and enhance the phagocytic 
activity of microglial cells following SA challenge19. How Pam3 pretreatment modulates global retinal innate 
responses in bacterial endophthalmitis is not known. Thus, considering the complex nature of host-pathogen 
interactions, we performed genome wide transcriptome analysis of SA-infected retinal tissue. Here, we estab-
lished a molecular signature of staphylococcal endophthalmitis, revealed several key pathways, and identified 13 
master regulator genes whose expression is modulated by TLR2 signaling.
Results
SA infection leads to temporal qualitative and quantitative gene expression alterations. 
Principal component analysis (PCA) demonstrated that 12 h and 24 h post-infection samples are separated from 
controls and 3 h post-infection samples along Principal Component 1 (PC1), which accounts for 65.7% of the 
variance in transcriptome data. This demonstrates that transcriptional differences were greater at later time points 
(e.g. 12 h, 24 h) of SA infection, as compared to an early time point, 3 h post-infection, and compared to unin-
fected controls. This also suggests that SA infection initially results in a potent minimal response, manifesting as 
an early qualitative and quantitative changes in gene transcription, which grows and spreads exponentially over 
time. The analysis also revealed distinctive clusters of samples consistent with the biological groups on the basis 
of the transcriptional profiles (Fig. 1).
Characterization of changes in transcriptional landscape due to SA infection. After preproc-
essing, we conducted group-wise comparisons using t-tests and fold change to identify differentially expressed 
genes at each time point after SA infection compared to control/vehicle samples. The group comparison iden-
tified the sets of genes that were significantly differentially expressed at each time point compared to vehicle 
and non-infection samples (Fig. S1A). All time points post-infection – (early (3 h), mid (12 h), and later (24 h) 
– evoked significant gene expression changes as compared to vehicle and uninfected control samples (Fig. 
S1A). The analysis identified a large number of differentially expressed genes 24 h post infection versus 3 h post 
Figure 1. Principal Component Analysis (PCA) of normalized expression data obtained from controls and 
SA infected samples. The first component with the highest variance (65.7%) is on the X-axis separating 12 and 
24 h post-infection samples from control samples and 3h post- infection samples. The second component, with 
the second highest variance (13.8%), is on the Y-axis, depicting a maximum variation of the 12 h post-infection 
samples from rest of samples. The biological replicates from control, 3 h, 12 h, and 24 h samples formed separate 
clusters on the PCA plot, indicating transcriptional differences among different groups.
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infection, indicating more pronounced transcriptional changes at later time points. Overall, the analysis identified 
1,234 genes that are differentially expressed at multiple time points after infection and might be strongly associ-
ated with the initiation and progression of infection (Fig. S1B). Out of 1,234 genes, 133 genes were consistently 
differentially expressed at all three-time points post SA infection as compared to control/vehicle samples. These 
genes are significantly associated with the response to DNA damage, cell death and apoptosis, and the regulation 
of transcription and RNA splicing (Fig. S1C).
SA infection elicits constitutive and temporal patterns of differential gene expression: 
Self-Organizing Map (SOM) Analysis. To identify gene expression patterns, we performed SOM analysis 
on 1,234 genes that were differentially expressed at multiple time points after SA infection, as identified by the 
group comparison analysis above34. Initially, differentially expressed genes were partitioned to 40 SOM patterns 
with different expression structures. Based on their similarity in gene expression patterns, we selected and merged 
these patterns into 4 distinct categories of related patterns. These 4 categories reflect the following patterns of gene 
expression changes: 1. “constitutive” upregulation; 2. “constitutive” downregulation; 3. “temporal” upregulation; 
and 4. “temporal” downregulation (Fig. 2). Overall, SA infection results in temporal expression changes, as well 
as a general shift in the baseline expression of many important genes. We defined constitutive downregulation 
patterns as those for which gene expression levels were consistently lower in all post SA infection samples com-
pared to both controls (Fig. 2A, Panel I). These genes depict an overall shift in gene expression following infec-
tion, independent of time of SA infection (early/mid/late), and might be responsible for sustaining the infection 
(Fig. 2B). We also observed a temporal downregulation pattern, where genes had the highest gene expression 
values at 3 h, with lower levels of expression at 12 h and the lowest levels at 24 h (Fig. 2A, Panel II). We defined a 
temporal upregulation pattern as the genes that showed a gradual increase in expression according to the length 
of infection. In other words, gene expression changes were low of insignificant at 3 h, higher 12 h, and the highest 
24 h post-infection (Fig. 2A, Panel III). A heat map of temporally dysregulated genes after SA infection is shown 
in Fig. 2C that depict changes in gene expression that are highly correlated with the time of SA infection and set 
of genes that may be responsible for initiating, sustaining, and spreading SA infection.
Figure 2. Significant transcriptional changes induced due to infection. (A) Self-organizing map (SOM) 
analysis of 1,234 genes commonly differentially expressed among different post-infection time points compared 
to controls. The SOM maps were clustered into ‘constitutive’ (similar expression changes at 3 h, 12 h, and 
24 h) and ‘temporal’ (progressive expression changes at 3 h, 12 h, and 24 h) expression changes on the basis of 
structure of expression pattern. The figure shows violin plots of selected 3 maps depicting constitutive down-
regulation (I), temporal down-regulation (II) and temporal up-regulation (III) patterns. Each cluster represents 
a set of genes that depict similar expression patterns and are biologically linked to a specific function. The X-axis 
represents different time points and groups, and the Y-axis represents gene expression on pseudoscale from 
− 3 to + 3. (B) Heatmap of constitutive genes depicting similar expression changes at 3 h, 12 h, and 24 h post-
infection. (C) Heatmap of temporal genes depicting progressive expression changes from 3 h, 12 h, and  
24 h post-infection. Columns represent samples, and rows represent genes. Gene expression levels are shown 
on a pseudocolor scale (− 1 to 1), with red denoting a high expression level and green denoting a low expression 
level.
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SA infection dysregulates biological gene sets and functions related to metabolism, cell cycle, 
apoptosis, and kinase activity. To gain insight into the functional consequences of altered gene expres-
sion due to SA infection, we employed the Database for Annotation, Visualization and Integrated Discovery 
(DAVID). The constitutively regulated genes that show significant enrichment in clusters of the gene ontology 
(GO) categories related to metabolism (e.g. Nucleotide, Macromolecules), RNA splicing, and protein ubiquiti-
nation are shown in Fig. S2A. The most highly enriched clusters of the GO categories regulated temporally by SA 
infection include those related to programed cell death, the inflammatory response, carbohydrate binding, cell 
activation, the immune response, and actin binding related genes (Fig. S2B). Further functional analysis on genes 
temporally associated with SA infection showed upregulation of genes linked to cellular movement, immune 
cells trafficking, inflammatory response, and cellular growth and proliferation, as well as downregulation of genes 
linked to cell death and survival and tissue morphology (Fig. S2C).
SA infection temporally activated multiple immune response and inflammation-related path-
ways. As a complementary approach, pathway enrichment analysis was performed on genes with tempo-
ral transcriptional changes following SA infection. Pathways enrichment was assessed using Ingenuity Pathway 
Analysis (IPA) tools. This IPA demonstrated significant enrichment of temporally altered genes involved in 
numerous inflammatory response and immune system-related pathways (Fig. 3 and Table 1). In keeping with 
the inflammatory properties of SA infection, JAK/Stat Signaling, IL-17 A, IL-10, IL-6, and IL-9 acute phase sig-
naling pathway, interferon signaling, glucocorticoid receptor signaling, iNOS signaling, Toll-like receptor sign-
aling, CD40 signaling, and the STAT3 pathways were marked by an overall up-regulation of relevant transcripts. 
Additionally, constitutively altered genes depicted significant enrichment in CD27 signaling, estrogen receptor 
signaling, protein ubiquitination, AMPK, and apoptosis-related (TNFR-1) pathways (Table 1).
Systems biology analysis of SA infection transcriptome changes identified activation of 
immune and inflammatory responses as the key master regulator. To further understand the 
molecular mechanisms of SA infection, we performed systems biology analysis on constitutively or temporally 
altered transcripts. The systems biology analysis was performed using a master regulator approach that assists 
in identifying the key transcriptional regulators that might be responsible for pathophysiology. The regulatory 
analysis depicted significant activation of multiple major immune and inflammation regulators, including STAT1, 
STAT3, IL-6, NFKB2, JUN, SPP1, IL-1β , CSF1, CXCL2, IGF1, CEBPB, and PTPN1 (Fig. 4). The systems biology 
analysis clearly depicts activation of the innate immune response of the host via activation of the key transcrip-
tional regulator NF-κ B, as well as interferons and cytokines.
Molecular Effects of Pam3 Treatment to blunt SA infection. We previously reported that TLR2 acti-
vation induces protective responses in SA endophthalmitis19,20. To understand the molecular effects of TLR2 ligand 
(Pam3) treatment, we performed whole genome transcriptome profiling on Pam3 treated (PAM3) and PAM3–
pretreated and SA infected (Pam3+ SA) samples. The transcriptome analysis identified 406 and 1,090 differen-
tially expressed genes in Pam3 and Pam3+ SA treated samples, respectively, as compared to controls (Fig. S3A). 
The analysis identified 85 transcripts that are commonly differentially expressed in Pam3 and PAM3+ SA treated 
samples (Fig. S3B). These common transcripts are significantly linked to biological processes involved in cellular 
development, cellular growth and proliferation, and cellular morphology (Fig. S3C). Further pathway enrichment 
analysis on these transcripts showed a significant overrepresentation in protein ubiquitination, DNA methylation, 
lactose degradation, and apoptosis signaling pathways (Fig. S3D).
Figure 3. Comparison of affected pathways between constitutively and temporally altered genes post-
infection. Pathways significantly enriched in constitutive versus temporal post-infection altered genes. 
Pathways affected by constitutively altered genes are shown as black bars, while those affected by temporally 
altered genes are shown as grey bars.
www.nature.com/scientificreports/
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Counter regulation of SA infection mediated transcriptome changes by PAM3. The 
PAM3-mediated development of a microenvironment suitable for combatting SA infection was studied by PAM3 
counter regulation analysis. SOM counter analysis was performed on 1,234 differentially expressed genes induced 
by SA infection to identify the effects of PAM3 treatment on these genes. Counter-regulation means that PAM3 
treatment down-regulates genes that are up-regulated in SA infection vs. controls and vice versa. SOM clustering 
of differentially expressed transcripts post-infection to 10 bins was performed to identify transcripts that are 
counter regulated by PAM3 treatment. Bins of transcripts manifesting different degrees of counter regulation 
were identified and further filtered on the basis of magnitude of counter regulation. The final list of counter 
regulated genes was generated by considering genes that are counter regulated by a magnitude of fold change 
(FC) > 1.2–1.5 on treatment, as compared to their expression 24 h post-SA infection. The analysis identified genes 
that were temporally regulated by SA infection and counter regulated by PAM3 treatment (Fig. 5A). Figure 5A 
shows violin plots which reveal two major themes in gene expression pattern counter regulation by PAM3. Panels 
I and II of Fig. 5 shows the up-regulation of temporally down-regulated genes due to SA infection (with slight 
variations in the temporal gene expression pattern) upon treatment with PAM3, while Panels III and IV show 
the down-regulation of temporally up-regulated genes due to SA infection upon PAM3 treatment. Furthermore, 
PAM3 pre-treatment creates a microenvironment by counter regulating the SA infection signature, which is 
maintained 24 h post-secondary SA infection after PAM3 treatment (Fig. 5A; last time point shown). The heat 
map of the 280 SA infection signature genes clearly shows this counter regulation pattern by PAM3 treatment 
(Fig. 5B).
The SA infection signature genes that were counter regulated by PAM3 treatment were further investigated for 
functional and pathway enrichment using Ingenuity Pathway Analysis (IPA) tools. The functional groups most 
significantly enriched related to two major categories, namely, inflammatory processes and basic cellular func-
tions. The top inflammatory functional categories included cellular movement, inflammatory response, immune 
cell trafficking, immunological disease and infectious disease, and the top functions associated with general cellu-
lar functioning included cellular development, cell growth and proliferation, hematological system development 
and function, cell death and survival, and cellular morphology (Fig. 6A). Furthermore, pathways enrichment 
analysis on PAM3 counter regulated genes depicted a significant enrichment in multiple inflammatory pathways 
like IL-17 A signaling in fibroblasts, IL-10 signaling, IL-6 signaling, acute-phase response signaling, JAK/STAT 
signaling, and Toll-like receptor signaling (Fig. 6B).
PAM3 treatment results in significant suppression of master regulators of SA infection. Systems 
biology analysis of genes associated with the PAM3 counter regulation signature further identified the major net-
works formed by these genes and predicted the master regulators and there up- or down-regulation based on the 
expression patterns of the network genes. It is very evident from the analysis that the magnitude of differential 
expression and its directionality are reversed for these PAM3 counter regulation signature genes before and after 
Figure 4. Interactive network of the regulatory molecules and their down-stream targets that are 
significantly activated or inhibited during the temporal post-infection phase. Top regulatory genes were 
selected on the basis of enrichment score, as derived from the dysregulation of target molecules and their fold 
changes due to infection. In this network, activated and inhibited regulatory molecules are shown with orange 
and blue color, respectively. The regulatory molecules include the activation of multiple key inflammation 
related molecules, including NFKB2, IL-1β , CXCL2, and JUN. Also, in this network, each node represents a 
gene and each edge represents an interaction. The up-regulated and down-regulated target genes are shown with 
shades of red and green colors, respectively.
www.nature.com/scientificreports/
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PAM3 treatment (Fig. 7). The hub genes like IL-6, JUN, and CXCL2 are predicted to be up-regulated before 
PAM3 treatment and are predicted to be down-regulated after PAM3 treatment based on the observed expression 
levels of the PAM3 counter regulatory signature genes. Similarly, IGF1 is predicted to be down-regulated master 
regulator before PAM3 treatment and up-regulated after treatment.
Validation of SA infection master regulators at mRNA and protein levels. To validate the 
microarray data, the expression profile of all 13 master regulator genes (IGF1, Jun, STAT3, NUPR1, CEBPB, 
CSF1, CyR61, EGFR1, SPP1, TGM2, IL-6, IL-1β , and CXCL2) was confirmed by qRT PCR in both WT and 
TLR2 KO mouse retina. Our data revealed that TLR2 deficiency resulted in the downregulation of the hub genes 
(Fig. 8). The overlay of qRT-PCR and microarray expression profiles of the hub genes in WT mouse retinas 
Figure 5. Counter regulation of gene expression by PAM3 pre-treatment, as determined by transcriptome 
profile comparison of temporal samples with and without PAM treatment prior to infection. (A) SOM maps 
representing infection-related gene clusters that were significantly counter regulated by PAM3 pre-treatment. 
PAM3 pre-treatment counter regulated 280 genes out of the approximately 1,200 genes altered due to infection. 
(B) Heatmap of genes that are significantly counter regulated due to PAM3 pre-treatment. Columns represent 
samples, and rows represent genes. Gene expression levels are shown on a rainbow pseudocolor scale (− 3 to 3), 
with red denoting high expression levels and blue denoting low expression levels.
Figure 6. Functional and Pathway enrichment analysis of genes significantly counter regulated by PAM3 
pre-treatment. (A) Functional enrichment analysis depicting the counter regulation of multiple functional 
categories related to the immune and inflammatory response, as well as cell death and survival. (B) Pathway 
enrichment analysis depicting the counter regulation of multiple inflammatory and cell adhesion response 
related pathways, including IL-10 signaling, IL-6 signaling, JAK/STAT signaling, TNFR2 signaling, and Toll-like 
receptor signaling. The significance of the effect of PAM3 pre-treatment on functional and pathway categories 
was determined using multiple test corrected Fisher’s exact test p values.
www.nature.com/scientificreports/
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showed strong correlation (Fig. S4). To determine whether the master regulator genes are expressed at the protein 
level and whether their expression is modulated by Pam3 treatment, we performed IHC, Western blot, and ELISA 
assays (Fig. 9). To this end, our data showed that SA strongly induced the expression of CEBPB and STAT3 in the 
retina, whereas the expression of NUPR1 and IGF1 was relatively low, as assessed by IHC (Fig. 9A). The induced 
expression of CEBPB and STAT3 was further confirmed by Western blot analysis (Fig. 9B). The protein levels of 
the master regulatory cytokines IL-1β and IL-6 and chemokine CXCL2 were accessed by ELISA. As expected, 
compared to uninfected controls, SA infection resulted in the increased expression of IL-1β , IL-6, and CXCL2 
and their levels were significantly lower in Pam3 pretreated retinal tissue (Fig. 9C). To ascertain whether Pam3 
pretreatment protected retinal tissue from SA endophthalmitis, H&E staining was performed. As anticipated, 
SA causes cellular infiltration and retinal folding/damage; however, these pathological changes were abolished in 
Pam3-pretreated eyes (Fig. 9D).
Discussion
Endophthalmitis is an inflammatory disease caused by intraocular microbial infections, which result in blind-
ness in some patients. Severe vision loss in endophthalmitis is the result of retinal damage caused by pathogen 
derived virulence factors (e.g., toxins) and excessive host inflammatory responses35,36. Although the mechanisms 
underlying the initiation and resolution of intraocular inflammation in bacterial endophthalmitis are not fully 
understood, our previous studies implicated the role of TLRs26. We demonstrated that, once bacteria gain access 
to the inside the eye, retinal residential cells (microglia and Müller glia) become activated and initiate retinal 
innate responses2,19,32,33 due, at least in part, to TLR2 signaling in case of SA infection26,37. We also demonstrated 
Figure 7. Master regulatory molecules counter regulated by PAM3 Pre-treatment to improve the outcome 
following infection. 
Ingenuity canonical pathways Molecules
Constitutive
Estrogen Receptor Signaling TAF4B, THRAP3, TAF5, MED1, MED13L, MED4, TAF15
CD27 Signaling in Lymphocytes MAP3K12, MAP2K7, IKBKG, IKBKAP
TNFR1 Signaling IKBKG, MADD, XIAP
Protein Ubiquitination Pathway DNAJC28, DNAJC24, UBR1, ANAPC5, UBE3A, XIAP, SKP2,
DNAJC11
AMPK Signaling CAB39, PPP2R3A, STRADA, PPP2R2B, RPTOR
Temporal
IL-17A Signaling in Fibroblasts FOS, JUN, NFKBIA, LCN2, CEBPD, CEBPB, NFKB2, IL6,
NFKBIZ, MAPK11
IL-10 Signaling IL33, FOS, IL4R, JUN, NFKBIA, IL1B, STAT3, IL1R1, NFKB2,
IL6, FCGR2B, MAPK11
IL-6 Signaling IL6R, STAT3, IL1R1, CEBPB, NFKB2, IL6, MAPK11, IL33, FOS,
NFKBIA, JUN,PIK3C3,IL1B,ATM,MCL1
JAK/Stat Signaling FOS, PIK3C3, PIAS1, CDKN1A, CISH, PTPN1, SOCS2,
STAT3, IL6, STAT1, ATM
IL-9 Signaling PIK3C3, CISH, SOCS2, BCL3, STAT3, NFKB2, STAT1, ATM
Table 1.  Top signaling pathways and their associated molecules.
www.nature.com/scientificreports/
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Figure 8. qRT-PCR analysis of regulatory molecules for validation of gene expression data. C57BL/6 or 
TLR2−/− (B6 background) mice were intravitreally injected with S. aureus (SA) for the indicated time points. 
Total RNA was extracted, reverse transcribed, and subjected to qRT-PCR using specific primers for thirteen 
master regulator genes (IGF1, Jun, STAT3, NUPR1, CEBPB, CSF1, CyR61, EGFR1, SPP1, TGM2, IL-6, IL-1β , 
and CXCL2) with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as the control. Modulations of gene 
expression were expressed as relative fold changes with respect to the GAPDH control. Statistical analysis was 
www.nature.com/scientificreports/
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that TLR2 ligand (Pam3Cys) pretreatment protected mice from SA endophthalmitis, which is, in part, mediated 
by reduced inflammatory response and the increased production of antimicrobial peptides20. To further delineate 
the protective mechanisms evoked by TLR2 engagement and to establish a molecular signature of staphylococcal 
endophthalmitis, in this study, we determined the differential gene expression in uninfected, SA-infected, and 
Pam3 pretreated and SA-infected mouse retinas.
Transcriptome analysis of retinal tissue at 3 h, 12 h, and 24 h after infection provides deep insight into the gene, 
pathway, and biological networks that are perturbed during different phases of infection. Here, we established that 
SA infection results in either constitutive or temporal dysregulation of host genes. The constitutive patterns con-
sist of genes that are immediately dysregulated upon SA infection and remain dysregulated throughout the infec-
tion. It is possible that these genes may be vital to the survival of the pathogen. Functional analysis of these genes 
depicted significant enrichment in metabolic and cellular maintenance machinery and apoptosis-related biolog-
ical processes. The changes in gene expression demonstrated significant association with estrogen signaling, pro-
tein ubiquitination, and AMPK signaling. It is well known that protein ubiquitination plays a critical role in the 
initiation and termination of innate response signal transduction pathways, such as nuclear factor κ B (NF-κ B) 
pathway, which evokes a wide range of host inflammatory responses to inhibit bacterial growth38. In addition, 
ubiquitination can induce the host cell to kill pathogens via proteasome and phagolysosome-mediated degrada-
tion pathways. Some pathogens can hijack ubiquitination pathways to evade the host immune response39. This 
phenomenon is well demonstrated among Gram-negative bacteria such as Salmonella, Shigella, and Pseudomonas 
spp., where the type III and type IV secretion systems (T3SSs and T4SSs) are particularly involved in targeting 
host ubiquitin systems40. Although S. aureus produces a variety of virulence factors, including toxins, to our 
knowledge their role in disrupting ubiquitin pathways has not been reported. Our study, showing a constitutive 
dysregulation of ubiquitination pathways (e.g. UBE3A) in SA-infected retinal tissue, indicates that SA may utilize 
these mechanisms for survival in the eye and that the activation of specific ubiquitin mechanisms may promote 
bacterial clearance. Similarly, SA endophthalmitis was found to alter the expression of genes/pathways involved 
in cellular metabolism, including increased fatty acid synthesis and reduced energy/ATP generating signaling 
pathways, such as AMPK signaling (Table 1). Indeed, we confirmed these transcriptome findings and evaluated 
the role of AMP-signaling in SA endophthalmitis. Our data (manuscript under review) revealed that SA infection 
resulted in the downregulation of AMPK activity, an enzyme that plays a key role in cellular energy homeostasis. 
This reduction in AMPK activity (phosphorylation) coincided with increased inflammation and the restora-
tion of AMPK phosphorylation using a specific activator, AICAR, attenuated inflammation in SA-infected eyes. 
Together, these observations support the biological significance of the results reported in the current study.
The genes with temporal transcriptome changes demonstrated that SA infection targeted multiple pathways 
and biological processes that were central to immune and inflammatory responses and cellular growth and pro-
liferation, as expected, but also revealed novel pathways impacted by SA infection, such as the glucocorticoid 
receptor signaling, RANK/RANKL signaling, protein ubiquitination, and Notch signaling. Pathway analysis 
revealed an overall activation of multiple immune and inflammation pathways, including JAK/STAT signaling, 
interleukin pathways (e.g., IL-10, IL-6, IL-9, IL-8, IL-17 A), interferon signaling, and Toll-like receptor (TLR) sig-
naling. The induced expression of genes/molecules involved in TLR signaling was expected, as extensive studies 
from our2,19,20,26,32,41 and other28,30,42,43 laboratories have demonstrated an essential role of TLRs in retinal innate 
responses in bacterial endophthalmitis. Interestingly, among the five prominent signaling pathways (Table 1) 
with temporal changes, IL-17 A and JAK/STAT were the most significantly affected. The role of these pathways 
in the pathogenesis of bacterial endophthalmitis is yet to be elucidated. Previous studies have shown that IL-17 
induces protective innate immunity against SA infection in the skin44. Moreover, IL-1, TLR2, and IL-23 were 
found to promote neutrophil recruitment to the SA-infected skin by inducing IL-17 production in γ δ T cells44. 
IL-17 deficiency diminished lung defenses against SA by reducing the production of antimicrobial peptides and 
neutrophil-recruiting chemokines45. The role of IL-17 has also been elucidated in fungal keratitis where a subset 
of neutrophils was assigned as the cellular source of IL-1746,47. Similarly, a transcriptome study of SA-infected cor-
neal epithelium revealed the induced expression of CCL2048, a strong Th17 chemoattractant49. Given the strong 
relationship of IL-17 and SA infection, it would be interesting to investigate the role of IL-17 signaling in SA 
endophthalmitis by inhibition or neutralization studies and confirm the transcriptome findings at the protein 
level.
Systems biology analysis of the SA infection signature assisted in generating a global picture of the crosstalk 
between the pathways/genes involved in pathophysiology and to highlight the master regulators and key pro-
cesses that are most critical for SA endophthalmitis. The systems biology analysis identified multiple immune 
system and inflammation molecules (e.g., STAT3, STAT1, CEBPB, JUN, IGF1, SPP1, NFKB2, IL-1β , and CSF1) 
as master regulators that are activated upon infection. On the other hand, genes linked to cell proliferation and 
apoptosis (e.g., BCL6, APOE, PDCD4, and RARES2) emerged as the top inhibited master molecules due to infec-
tion (Fig. 4).
Similar to NF-KB signaling, JAK/STAT signaling has been studied extensively as is critical for in that it con-
verges diverse signals from the immune system to perform multiple functions, including resisting infection, 
maintaining immune tolerance, and enforcing innate barrier functions50,51. Indeed, our data show significant 
upregulation of JAK/STAT signaling and its associated genes/molecules, including IL-6, which implies an impor-
tant role of this pathway in SA endophthalmitis. It has been shown that IL-6, a pleiotropic cytokine, plays a 
performed using one-way ANOVA (*) and Student’s t-test (§) for comparisons of control versus stimulated mice 
over time, and C57BL/6 vs. TLR2−/− mice, respectively. Data points and error bars represent the mean ± SD of 
triplicates from three independent experiments. (*§P < 0.05; **§§P < 0.005; ***§§§P < 0.0005).
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central role in the immune responses activated through the TNF-α and NF-κ B pathways, as a first line of defense 
against infection in the acute-phase response52. Pathway enrichment analyses confirmed that the IL-6 signaling 
Figure 9. Analysis of regulatory molecules at the protein level. C57BL/6 mice were given intravitreal 
injections of PBS (control) or SA/Pam3. After 24 h, enucleated eyes were either embedded in OCT or fixed 
in paraffin. Cryosections were subjected to immunostaining (A), as described in material and methods. 
From a separate group, eyes were enucleated and lysates were made in PBS using a tissue lyser. Retinal lysates 
were subjected to Western blotting to validate protein expression (C, left panel). The band intensities were 
quantitated by densitometric analysis using Image J and presented as bar graph using β -actin as control (C right 
panel). Protein levels of inflammatory cytokines were assessed by ELISA (B). Paraffin embedded eyes were 
subjected to H&E staining for histological analysis (D). (*P < 0.05, **P < 0.005, ***P < 0.0005 ANOVA).
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pathway is significantly enriched among temporal post-infection altered genes (Fig. 6). IL-6, upon receptor bind-
ing, activates STAT3 via the gp130/JAK/STAT pathway53,54. STAT3 is known to be important in the development 
of the immune system, in the maintenance of immune tolerance/privilege, and in active tumor surveillance54–56, 
among other cellular functions. Similar to IL-6, IL-10 confers broad anti-inflammatory properties, which can 
be amplified by a feed forward loop via the STAT3-induced expression of IL-1057,58. In the absence of inhibition 
by SOCS protein, the JAK/STAT pathway is also activated by IGF-1, another master regulator identified by our 
systems analysis. Given the important role of JAK/STAT signaling in autoimmune disease, cancer, and inflamma-
tory diseases51,59, this pathway has become an attractive target for drug development. There are a wide variety of 
agents from the nonselective glucocorticoids to the selective JAK/STAT inhibitors with considerable therapeutic 
potential. Examples, including Ruxolitinib (JAK1 and JAK2 inhibitor), and tofacitinib (JAK3 inhibitor, approved 
for rheumatoid arthritis) are being evaluated in various clinical trials for psoriasis, inflammatory bowel disease, 
transplant rejection, and juvenile arthritis60. The availability of these FDA approved drugs targeting JAK/STAT 
signaling provides us the opportunity to test their efficacy in endophthalmitis or other ocular infections.
Many immune system specific transcription modulators are also temporally dysregulated post-infection. The 
CCAAT/enhancer-binding protein beta (C/EBPβ ) has been shown to bind the IL-1 response element of the IL-6 
gene and several other acute-phase response genes. C/EBPβ is a member of the C/EBP subfamily of leucine 
zipper containing transcription factors61,62 and is involved in increasing the expression of several target genes, 
including the pro-inflammatory cytokines IL-4 (T and B cell activation, proliferation, and differentiation)63, IL-5 
(B cell activation)64, and IL-6 & TNF-α (initiation of acute phase response and regulation of innate and adaptive 
immunity)65,66. Interestingly, in addition to inflammation modulators, transcription factors, and cytokines, extra-
cellular structural proteins, like SPP1, are also among the temporally dysregulated genes. The SPP1 gene codes for 
secreted phosphoprotein-1 (SPP1), more commonly known as osteopontin (OPN). OPN expression is increased 
in response to pro-inflammatory cytokines TNF-α and IL-1β , as well as other mediators of acute inflammation 
like angiotensin II, TGF-β , and parathyroid hormone (PTH)67. OPN, being a highly negatively charged extracel-
lular structural protein, is capable of binding to integrin receptors on many cells types, including leukocytes67,68. 
Therefore, it has been suggested that OPN may play a role in immune cell adhesion, migration, and survival. 
Chemotactic response modulators like CSF1 are among the temporally dysregulated genes. The CSF1 gene codes 
for colony stimulating factor 1 (CSF1), also called macrophage colony stimulating factor (M-CSF). M-CSF acts 
locally within virtually all tissues of the body to increase the cellular activity of macrophages and the recruitment, 
and subsequent maturation and differentiation, of naïve monocytes to the site of infection and/or trauma69,70.
Another key master regulator identified in our study is IL-1β , a potent activator of immune responses directed 
against bacterial infections71. IL-1β mediates the migration of leukocytes, induces fever, and promotes the activa-
tion and polarization of T cells72. Compared to other inflammatory cytokines implicated in endophthalmitis, the 
expression and release of bioactive IL-1β are tightly regulated and require at least two distinct stimuli. The first is 
an inflammatory stimulus that results in the intracellular accumulation of pro-IL-1β , while the second stimulus 
activates a multiprotein complex, referred to as the “inflammasome”, which controls the Caspase-1 mediated 
cleavage of pro-IL-1β to active IL-1β 73. Indeed, we have observed that the mouse retina and cultured microglia 
cells express components of the inflammasome (NLRP3, ASC and Caspase-1) and that SA challenge induces 
mRNA and protein expression of NLRP3 (unpublished, ARVO 2012 poster, Abstract # 2770). The counter reg-
ulation of IL-1β expression (Fig. 9) by Pam3 pretreatment and its reduced levels in TLR2 KO mice both imply 
a potential cross-talk between NLRP3 and TLR2 signaling, a current area of investigation in our laboratory. 
Similarly, the molecular determinants of inflammasome priming and activation in staphylococcal endophthal-
mitis need to be explored.
In summary, we present a comprehensive transcriptomic analysis of retinal gene expression at the early stages 
of staphylococcal endophthalmitis. Our systems biology analysis revealed that 13 hub genes, including the clas-
sical inflammatory genes (IL6, NFKB2, JUN, IL-1β , and CXCL2) which regulate retinal innate responses during 
infection. Moreover, Pam3 preconditioning dramatically altered the expression of these master regulators, sug-
gesting that Pam3 is a potential candidate for the development of therapeutic modalities to prevent excessive 
inflammation and tissue damage in endophthalmitis. A thorough mining of our data on the basis of master reg-
ulators that are perturbed in response to infection demonstrated that key focus molecules are mostly involved in 
the innate immune response and that pretreatment of the host with innate immune activators increases resiliency 
and blunts immune system activation. Moreover, the identified key pathways can be targeted therapeutically to 
prevent or treat endophthalmitis.
Materials and Methods
Mice and Ethics Statement. C57BL/6 and TLR2 KO mice were purchased from the Jackson Laboratory 
(Bar Harbor, ME). The animals were housed in a restricted access DLAR facility at the Kresge Eye Institute, 
were maintained in a 12 h light to 12 h dark cycle, and fed LabDiet rodent chow (Labdiet Pico lab Laboratory, St 
Louis, MO) and water ad libitum. Female mice of 8–12 weeks of age were used throughout all experiments. The 
study was approved by the Institutional Animal Care and Use Committee (IACUC) of Wayne State University 
under protocol # A 08-02-13. All experimental procedures/methods were carried out in accordance with the 
approved guidelines of the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use 
of Animals in Ophthalmic and Vision Research.
Induction of Endophthalmitis. The mice received intravitreal injections of 1.0 μ l of PBS containing 
~5,000 CFU of SA strain RN6390 (left eye) to induce endophthalmitis, as described previously20,41. The right 
eyes were left uninfected as a normal control. In the control group, the eyes were injected with sterile PBS. In 
the Pam3 treatment group, Pam3 (0.1 μ g) was injected intravitreally. In the Pam3 pretreatment group, Pam3 
(0.1 μ g) was injected 24 h prior to SA injections. Following 3, 12, and 24 h infection, the mice were euthanized and 
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the neuroretina was carefully removed without RPE or choroid and preserved in RNAlater® solution (Ambion, 
Grand Island, NY) for downstream processing.
Microarray. The mouse tissue gene expression profile was assessed at multiple time points (3 h, 12 h, 24 h) 
post-infection and PAM3 treatment using HT 430 2.0 PM Array plate (Affymetrix, Santa Clara, CA) containing 
> 45,000 probes, allowing for the analysis of > 30,000 well characterized mouse genes. Expression data were pre-
processed using the Robust Multichip Average (RMA) method in R using the Bioconductor and associated pack-
ages74. Normalized high-quality arrays data were included in the unsupervised and supervised bioinformatics 
analysis. To identify statistically significant differences in gene expression, the microarray analysis was performed 
on at least 2–3 separate biological replicates at each time point.
Unsupervised Analysis. The unsupervised analysis was performed using Principal Component Analysis 
and Hierarchical clustering to identify outliers and correlation among samples. Before PCA and Clustering, nor-
malized data were preprocessed to remove transcripts with low expression for reducing false-positive results. 
Only transcripts with absolute expression ≥ 40 in at least 5% of the samples were included.
Supervised analysis to identify differentially expressed genes and patterns. We used absolute 
fold changes (FC) and p values (student t-test) between control or vehicle treated samples and infected samples 
as the cut-off criteria to identify differentially expressed genes at each time point. The genes with an absolute fold 
change > 1.5 and a p value < 0.05 are considered to be differentially expressed. The fold change was calculated 
over multiple biological replicates to reduce false positive rates. It is well accepted in several studies that temporal 
analysis is the most effective strategy to identify the least false positive genes that are altered in a time-dependent 
manner to external stimulant using a low cutoff P value < 0.0575–77. To identify time and group dependent pat-
terns from differentially expressed genes, we have adopted the Self Organizing Map (SOM) clustering technique34. 
We performed SOM clustering on transcript expression values using the Pearson correlation coefficient based 
distance metrics and a target of 40 groups. The analysis will help in identifying the genes depicting temporal 
expression changes (i.e., expression changes correlated with time of infection), as well as genes depicting expres-
sion changes only at early or late time points after infection. The genes depicting significant early, late, or temporal 
expression changes following SA infection will henceforth be collectively referred to as the SA infection signature.
Counter Regulation Analysis. To identify genes that are involved in the treatment of infection, upon treat-
ment or pre-treatment with PAM3, we performed counter regulation analysis on the transcripts from the SA 
infection signature that are differentially expressed due to SA infection. Counter regulation means that PAM3 
treatment down-regulates genes that are up-regulated in SA infection and vice versa. SOM clustering of differen-
tially expressed transcripts to 20 bins was performed to identify transcripts that are counter regulated by treat-
ments. Bins of transcripts manifesting different degrees of counter regulation were identified and further filtered 
on the basis of magnitude and p value based significance of counter regulation. The final list of counter regulated 
genes was generated by considering genes that are counter regulated by a magnitude of fold change (FC) > 1.2 
compared to the degree of gene expression at 24 h after SA infection.
Gene Ontology (GO) Analysis. To identify over-represented GO categories in differentially expressed 
genes from different comparisons, we used the Biological Processes and Molecular Functions Enrichment 
Analysis available from the Database for Annotation, Visualization and Integrated Discovery (DAVID)78. A 
p-value is assigned to each category on the basis of enrichments using jackknife Fisher exact probabilities.
Pathway and Functional Analyses. Ingenuity Pathway Analysis (IPA) (Qiagen) was applied to early, late, 
or temporal expression changes due to SA infection and/or PAM3 treatments to identify biological pathways 
significantly over represented at the time of infection and counter regulated by PAM3 treatment. It calculates 
p values using Fisher’s exact test for each pathway and functions according to the fit of the user’s data to IPA data-
bases. The pathways with p-values < 0.05 were considered significantly affected.
Interactive Network Analysis. In addition to individual gene analysis, interactive network analysis was 
performed as the genes from different significantly affected pathways and functions crosstalk to each other, often 
resulting in some degree of pathophysiology. In the case of interactive networks, all of the identified genes were 
mapped to genetic networks available in the IPA database and were ranked by the score. The score (− log p value) 
is calculated using Fisher’s exact test and indicates the likelihood that a gene will be found in a network due to 
random chance.
Regulator Module Analysis. The regulatory module analysis was used to identify the cascade of upstream 
transcriptional regulators involved in the observed gene expression changes to help identify key regulators (mas-
ter regulators) and understand the underlying biological mechanisms. The analysis will help in identifying first 
which transcription regulators are significantly affected by the treatment, as well as determine whether they are 
activated or inhibited. The significance of overlap was determined using one-tailed Fisher’s exact test.
RNA extraction and real time PCR analysis. Total RNA was extracted from retinal tissue using an 
RNeasy® Mini Kit, as per the manufacturer’s instruction (Qiagen, Germantown, MD). Some RNA was used for the 
microarray analysis, and the remaining RNA was used for gene validation. cDNA was synthesized using 1.0 μ g of 
total RNA using a Maxima first strand cDNA synthesis kit, as per the manufacturer’s instructions (Thermo scientific, 
Rockford, IL). Primers were purchased from Integrated DNA Technologies (Coralville, IA). PCR was performed 
using a StepOnePlus™ instrument (Applied Bio system, Grand Island, NY). The quantification of gene expression 
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was determined via the comparative Δ Δ CT method. The expressions in the test samples were normalized to endog-
enous reference GAPDH levels. All assays were performed in triplicate and repeated at least twice. The data are pre-
sented as the mean ± the SD and statistical analysis were performed using one-way analysis of variance (ANOVA).
ELISA, Western Blotting, Histopathology, and Immunostaining. The detailed methods for valida-
tion of target molecules using ELISA, Western Blotting, and Histopathology and Immunostaining are provided 
in our previous studies3,19,31,32,35.
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